Page last updated: 2024-09-03

msh (11-13) and Acute Brain Injuries

msh (11-13) has been researched along with Acute Brain Injuries in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Engelhard, K; Jahn-Eimermacher, A; Kornes, F; Luh, C; Pieter, D; Schäfer, MK; Schaible, EV; Sebastiani, A; Steinsträßer, A; Thal, SC	1

Other Studies

1 other study(ies) available for msh (11-13) and Acute Brain Injuries

Article	Year
Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice. PloS one, 2013, Volume: 8, Issue:8 Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Brain; Brain Injuries; Calcium-Binding Proteins; Gene Expression; Inflammation Mediators; Male; Melanocyte-Stimulating Hormones; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Peptide Fragments; Pro-Opiomelanocortin; Receptor, Melanocortin, Type 1; Receptor, Melanocortin, Type 4	2013

Article

Year

Single administration of tripeptide α-MSH(11-13) attenuates brain damage by reduced inflammation and apoptosis after experimental traumatic brain injury in mice.

PloS one, 2013, Volume: 8, Issue:8

Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Brain; Brain Injuries; Calcium-Binding Proteins; Gene Expression; Inflammation Mediators; Male; Melanocyte-Stimulating Hormones; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Peptide Fragments; Pro-Opiomelanocortin; Receptor, Melanocortin, Type 1; Receptor, Melanocortin, Type 4

2013